2,300
Participants
Start Date
March 18, 2020
Primary Completion Date
June 15, 2020
Study Completion Date
June 15, 2020
Treatment and prophylaxis
"Cases will be offered a therapeutic regimen hydroxychloroquine (200mg tablets) 800mg on day 1, and 400mg on days 2-7~Contacts will be offered a prophylactic regimen of hydroxychloroquine (200mg tablets) 800mg on day 1, and 400mg on days 2-7."
Standard Public Health measures
Isolation of patient and contact tracing as per national guidelines.
Departament de Salut, Barcelona
Collaborators (2)
Germans Trias i Pujol Hospital
OTHER
Department of Health, Generalitat de Catalunya
OTHER_GOV
Laboratorios Gebro Pharma SA
UNKNOWN
Laboratorios Rubió
UNKNOWN
Institut Catala de Salut
OTHER_GOV
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
OTHER